期刊文献+

奋乃静和利培酮对中老年精神分裂症患者体质量和糖脂代谢的影响 被引量:5

The effects of perphenazine and risperidone on body weight,glucose and lipid metabolism in the middle-aged and aged inpatients
下载PDF
导出
摘要 目的探讨奋乃静、利培酮对中老年精神分裂症患者体质量、糖脂代谢、催乳素及肿瘤坏死因子α的影响。方法将49例中老年精神分裂症患者随机分为奋乃静组(23例)和利培酮组(26例),共治疗8周。所有患者于疗前和治疗8周后测定体质量、空腹血糖、胰岛素、血脂和肿瘤坏死因子α水平。奋乃静组19例和利培酮组21例完成疗前和治疗8周后血清催乳素测定。结果治疗8周后,奋乃静组和利培酮组体质量、血清催乳素水平均显著增加,前组甘油三酯水平显著增高,后组高密度脂蛋白和空腹血糖水平显著降低。两组胰岛素、胰岛素抵抗及血清肿瘤坏死因子水平治疗8周前后无显著性差异。结论奋乃静和利培酮均可导致中老年精神分裂症患者体质量、血清催乳素水平显著增加,但两种药物对糖脂代谢的影响并不相同。 Objective To explore the effets of perphenazine and risperidone on body weight,glucose and lipid metabolism, prolacfin and tumor necrosis factor ot in the middle-aged and aged inpatiems with schizophrenia. Methods 49 inpafients with schizophrenia were randomly divided into perphenazine group (rt = 23 ) and risperidone group (n = 26) for eight weeks. Body weight, fasting blood glucose, insulin, blood lipids and tumor necrosis factor a were determined in all inpatients before treatment and after eight-week treatment. In 19 inpatients of perphenazine group and 21 inpatients of risperidone group,serum prolactin were determined before treatment and after eight-week treatment. Results After eight-week treatment, the body weight and serum prolactin levels increased significantly in both groups, the levels of blood triglyceride increased significantly in perphenazine group, the levels of blood high density lipoprotein and fasting blood glucose decreased significantly in risperidone group. The changes of the insulin, insulin risistance and serum tumor necrosis factor ot showed no significant difference in both groups. Conclusion Both perphenazine and risperidone can increase body weight and the serum prolactin levels, but perphenazine and risperidone differ in their effct on glucose and lipid metabolism.
出处 《四川精神卫生》 2008年第4期193-195,共3页 Sichuan Mental Health
关键词 奋乃静 利培酮 精神分裂症 糖脂代谢 催乳素 肿瘤坏死因子α Perphenazine Risper/done Schizophrenia Body weight glucose and lipid metabolism Prolacfin Tumor necrosis factor α
  • 相关文献

参考文献11

二级参考文献63

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2HOTAMISLIGIL GS,SHARGILL NS.SPIEGELMAN BM.Adipose expression of tumor necrosis factor-α:direct role in obesity-linked insulin resistance[J].Science,1993,259:87-91.
  • 3HOTAMISLIGIL GS,ARNER P.CARO JF,et al.Increased adipose tissue expression of tumor necrosis factor-α:in human obesity and insulin resistance [J].J Clin Invest,1995,95(5):2409-2415.
  • 4FRIED SK,ZECHNER R.Cachection/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels.syathesis and activity[J].J Lipid Res,1989,30:1917-1923.
  • 5KERN PA.SAGHIZADEH M.ONG JM,et al.The expression of TNF-α in human adipose tissue regulation by obesity,weight loss and relationship lipoprotein lipase[J].J Clin Invest,1995,95:2111-2119.
  • 6PRINS IB.NIESLER CV,WINTERFORD CM,et al.Tumor necrosis factor-α induced apotosis of human adipose cell[J].Diabetes,1997,46:1939-1944.
  • 7HOTAMISLIGIL GS,SPEIGELMAN BM.Tumor necrosis factor-a:a key component of the obesity-diabetes link[J].Diabetes,1994,43:1271-1278.
  • 8HOTAMISLIGIL GS,PERALDI P.BUDAVARI A. et al.IRS-1-mediated inhibition of insulin receptor lyrosine kinase activity in TNF-α and obesity-induced insulin resistance[J].Science,1996,271(5249):665-668.
  • 9STEPHENS JM,LEE J,PILCH PF.Tumor necrosis factor-a-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT-4 expression without a loss of insulin receptor-1 and signal transduction[J].J Biol Chem,1997,272(2):971-976.
  • 10HAUNER H.The mode of action of thiazolidinediones[J].Diabetes Metab Res Eev,2002,18(Suppl 2):S10-S15.

共引文献71

同被引文献45

  • 1张向荣,张志珺,姚志剑,刘文,牟晓冬,方群,孙静,侯钢.抗精神病药物治疗急性期体脂分布特征及其与血脂代谢相关性研究[J].中国神经精神疾病杂志,2004,30(4):271-274. 被引量:24
  • 2司天梅,舒良,于欣,马崔,王高华,白培深,刘协和,纪丽萍,师建国,陈宪生,梅其一,栗克清,张鸿燕,马弘.10省市抗精神病药使用现况的调查[J].中华精神科杂志,2004,37(3):152-155. 被引量:95
  • 3林建荣,张良,彭红军,冯容妹,温预关,郑东,侯静,黄煜坤,杨婵娟,梁绍材,徐贵云,邓德清,徐建雄,刘国雄,王春江,李英,张冬梅.氯氮平、氟哌啶醇和氯丙嗪对慢性精神分裂症患者糖、脂代谢及体质量的影响[J].中华精神科杂志,2006,39(2):73-77. 被引量:34
  • 4李琪勇,李家磊.阿立哌唑与氯氮平治疗精神分裂症对照研究[J].神经疾病与精神卫生,2006,6(3):207-208. 被引量:11
  • 5Allison DB, Mentore JL, Heo M, et al. Antipsychotieinduced weight gain: A comprehensive research synthesis [J]. Am J Psychiatry, 2005, 156 (11), 1686.
  • 6Leadbetter R, Shutty M, Pavalonis D, et al . Clozapine induced weight gain: prevalence and clinical relevance [J] . Am J Psychiatry, 2002, 149 (1) : 68272.
  • 7Melkersson K, Hulting AL. Antipsychotic drugs can affect hormone balance. Weight gain, blood lipid disturbances and diabetes are important [J] . Lakartidningen, 2001, 98 (48): 5462-5464, 5467-5469.
  • 8Morrato EH, Newcomer JW, Allen RR, et al. Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of medcaid claims data [J ] . Clin Psychiatry, 2008, 2 (2): 316-322.
  • 9Henderson DC, Cagl iero E, Grey C, et al. Clozapine , diabetes mellitus, weight gain and lipid abnormalities: a five 2year naturalistic study [ J ] . Am J Psyehiaty, 2000, 157 (6) : 975 -981.
  • 10Moore TA, Covell N H, Essock SM, et al. Real-world antipsychotic treatment practices [ J ] . Psychiatr Clin North Am, 2007, 30 (3): 401-416.

引证文献5

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部